Inovio Pharmaceuticals, Inc. (NASDAQ:INO)
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$67.4M
- Net margin
- —
Heavily indebted for what it earns.
- Total debt
- $8.0M
- Cash
- $31.5M
- Debt / equity
- 1.83
Owes more within a year than it holds to pay it.
- Current assets
- $39.9M
- Current liabilities
- $39.9M
- Current ratio
- 1.00
Consumes cash and must keep raising it.
- Operating cash flow
- -$80.6M
- Free cash flow
- -$80.8M
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 81.6M
- Share growth (1y)
- 110.2%
- Cash runway
- 5 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
INO Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 65.34 K |
| Revenue Growth (YoY) | — | -100.00 % | -100.00 % | — | -100.00 % | — |
| Cost of Revenue | 0.00 | 745.46 K | 754.05 K | 0.00 | 741.67 K | 0.00 |
| Gross Profit | 0.00 | -745.46 K | -754.05 K | 0.00 | -741.67 K | 65.34 K |
| SG&A Expense | 7.80 M | 7.88 B | 7.22 M | 7.88 M | 8.56 B | 9.02 M |
| R&D Expense | 10.83 M | 13.75 M | 10.26 M | 13.33 M | 14.17 M | 16.09 M |
| Operating Expenses | 18.62 M | 21.20 M | 16.72 M | 21.21 M | 22.34 M | 25.12 M |
| Operating Income | -18.62 M | -21.95 M | -17.48 M | -21.21 M | -23.08 M | -25.05 M |
| Pretax Income | -6.01 M | -19.68 M | 3.76 M | -45.50 M | -23.52 M | -19.69 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -6.01 M | -19.68 M | 3.76 M | -45.50 M | -23.52 M | -19.69 M |
| EPS (Basic) | -0.07 | -0.28 | 0.05 | -0.87 | -0.61 | -0.51 |
| EPS (Diluted) | -0.07 | -0.28 | 0.05 | -0.87 | -0.61 | -725.11 |
| Shares Outstanding | 81.62 M | 69.10 M | 69.00 M | 52.17 M | 38.83 M | 38.61 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.